Autopsy report · NCT00313287
Safety and Antiviral Activity Study of Clevudine 30 mg QD in Patient With Chronic HBV
Cause of deathNo reason given
Life of this trial
- Registered 2 years 10 months after it had already started.
- Ran for about 1 year 5 months before it stopped.
- 180 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Bukwang Pharmaceutical
- Sponsor type
- Industry
- Conditions
- Hepatitis B
- Interventions
- clevudine
- Participants
- 180
- Sites
- 33
- Countries
- South Korea
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.